洛克菲勒基金会与世界卫生组织于2021年11月8-10日举行战略对话，总结双方在全球卫生领域的合作进展并确定未来优先事项1。洛克菲勒基金会在过去二十年向WHO提供超过2530万美元的支持1，资金重点用于卫生应急项目、科学部门、流行病和疫情情报中心、基因组监测以及疫苗公平性等工作1。
洛克菲勒基金会领导Jane Ellison表示，基金会的支持对WHO实现公平的卫生结果至关重要1。双方共同领导COVID-19工具加速器（ACT-A）基因组监测工作组1，并承诺继续深化合作以最大化公共卫生影响1。WHO代表Dr Naveen Rao表示，洛克菲勒基金会致力于支持WHO成为强大高效的组织1。
The Rockefeller Foundation and the World Health Organization convened a strategic dialogue from November 8-10, 2021, to review and strengthen their partnership in advancing global public health 1. The foundation has invested over $25.3 million in supporting WHO's work over the past two decades, with particular emphasis on health emergency response programs, scientific initiatives, vaccine equity, and epidemiological intelligence 1.
During the discussions, both organizations identified key collaborative priorities moving forward. These include continued support for WHO's health emergency operations, strengthening the scientific division, enhancing epidemic and pandemic intelligence capabilities, advancing genomic surveillance efforts, and promoting equitable vaccine distribution 1. Jane Ellison, representing the Rockefeller Foundation, emphasized that the foundation's financial support is instrumental to WHO's mission of achieving equitable health outcomes 1. Dr Naveen Rao reinforced the foundation's commitment, stating that it is dedicated to helping WHO become a more robust and efficient organization 1. The two institutions also confirmed their joint leadership of the genomic surveillance working group under the COVID-19 Tools Accelerator, underscoring their collaborative approach to addressing pandemic challenges 1.
评论
还没有评论，欢迎留下第一条。